FDA APPROVES MERCK’S RSV SHOT DESPITE ALARMING INFANT TRIAL DATA Podcast Por arte de portada

FDA APPROVES MERCK’S RSV SHOT DESPITE ALARMING INFANT TRIAL DATA

FDA APPROVES MERCK’S RSV SHOT DESPITE ALARMING INFANT TRIAL DATA

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Del and Jefferey dive into the troubling numbers behind Merck’s new RSV shot for infants, recently greenlit by the FDA. Trial data revealed higher rates of deaths and severe respiratory illness in vaccinated babies, yet the FDA overlooked this concerning trial data.

Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
Todavía no hay opiniones